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Abstract 
The outbreak of a novel coronavirus SARS-CoV2 responsible for COVID-19 pandemic has caused 
worldwide public health emergency. Due to the constantly evolving nature of the coronaviruses, 
SARS-CoV-2 mediated alteration on post-transcriptional gene regulation across human tissues 
remains elusive. In this study, we systematically dissected the crosstalk and dysregulation of 
human post-transcriptional regulatory networks governed by RNA binding proteins (RBPs) and 
micro-RNAs (miRs), due to SARS-CoV-2 infection. We uncovered that 13 out of 29 SARS-CoV-
2 encoded proteins directly interact with 51 human RBPs of which majority of them were 
abundantly expressed in gonadal tissues and immune cells. We further performed functional 
analysis of differentially expressed genes in mock treated versus SARS-CoV-2 infected lung cells 
that revealed an enrichment for immune response, cytokine mediated signaling, and metabolism 
associated genes. This study also characterized the alternative splicing events in SARS-CoV-2 
infected cells compared to control demonstrating that skipped exons and mutually exclusive exons 
were the most abundant events that potentially contributed to differential outcomes in response to 
viral infection. Motif enrichment analysis on the RNA genomic sequence of SARS-CoV-2 clearly 
revealed an enrichment for RBPs such as SRSFs, PCBPs, ELAVs and HNRNPs illustrating the 
sponging of RBPs by SARS-CoV-2 genome. Similar analysis to study the interactions of miRs 
with SARS-CoV-2 revealed the potential for several miRs to be sponged, suggesting that these 
interactions may contribute to altered pos-transcriptional regulation across human tissues. Given 
the need to understand the interactions of SARS-CoV-2 with key pos-transcriptional regulators in 
the human genome, this study provides a systematic analysis to dissect the role of dysregulated 
post-transcriptional regulatory networks controlled by RBPs and miRs, across tissues types during 
SARS-CoV2 infection. 
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Introduction 
An outbreak of coronavirus disease (COVID-19) caused by the newly discovered severe acute 
respiratory syndrome coronavirus (SARS-CoV-2), started in December 2019, in the city of Wuhan, 
Hubei province, China. As of July 6, 2020, COVID-19 has expanded globally with more than 11.6 
million confirmed cases with over 538,000 deaths worldwide, imposing an unprecedented threat 
to public health (https://www.worldometers.info/coronavirus/). In the past two decades, 
coronavirus outbreak has resulted in viral epidemics including severe acute respiratory syndrome 
(SARS-CoV) in 2002 with fatality of 10% and middle east respiratory syndrome (MERS-CoV) in 
2012 with fatality of 36% [1-4]. Both SARS-CoV and MERS-CoV were zoonotic viruses 
originating in bat and camels respectively [5, 6]. However, the recurring emergence of highly 
pathogenic SARS-CoV, MERS-CoV and now SARS-CoV2 have indicated the potential for cross-
species transmission of these viruses thus raising a serious public health concern [7, 8]. SARS 
CoV-2 shares a sequence similarity of 80% and 50% with previously identified SARS-CoV and 
MERS-CoV respectively [9-12]. Since its emergence, rapid efforts have illustrated the molecular 
features of SARS-CoV-2 that enables it to hijack the host cellular machinery and facilitates its 
genomic replication and assembly into new virions during the infection process [13-16]. 
Coronaviruses carry the largest genome among all RNA viruses, ranging from 26 to 32 kilobases 
in length [12]. These viruses have a characteristic “crown” like appearance under two-dimensional 
transmission electron microscopy. SARS-CoV-2 is an enveloped positive -sense, single-stranded 
ribonucleic acid (RNA) viruses that belongs to the genus beta-coronavirus. Upon entry in the cell, 
SARS-CoV-2 RNA is translated into non-structural proteins (nsps) from two open reading frames 
(ORFs), ORF1a, and ORF1b [17, 18]. The ORF1a produces polypeptide 1a that is cleaved further 
into 11 nsps, while ORF1b, yields polypeptide 1ab, that is cleaved into 16 nsps [17, 18]. Since, 
SARS-CoV-2 utilizes human machinery to translate its RNA after the entry into the cell, it could 
possibly impact several RNA-binding proteins from the host to bind the viral genome resulting in 
altered post-transcriptional regulation. Next, the viral genome is used as the template for 
replication and transcription, mediated by non-structural protein, RNA-dependent RNA 
polymerase (RdRP) [18, 19]. SARS-CoV-2 encodes four main structural proteins: spike (S), 
envelope (E), membrane (M), and nucleocapsid (N) that are conserved and several other accessory 
proteins (3a, 6, 7a, 7b, 8, and 10) according to the current annotation (GenBank: NC_045512.2) 
[17, 20]. The spike protein, that has evolved the most during the COVID-19 outbreak, enables the 
virus to bind to angiotensin-converting enzyme 2 (ACE2) on the host cell membrane, following 
which it undergoes structural changes and subsequently allows the viral genome to make its way 
inside the host cell [21].  Infections caused by these viruses result in severe pneumonia, fever and 
breathing difficulty [22]. 
Protein-protein interaction map between SARS-CoV-2 and human proteins published recently has 
revealed several important targets for drug repurposing [23]. Given the evolving nature of 
coronaviruses that results in frequent genetic diversity in their genome, it is crucial to identify the 
regulators in humans that interacts with the viral genome and their cross talk that results in altered 
regulatory mechanisms in the host during the infection process. Therefore, it is imperative to 
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investigate the interacting post-transcriptional regulators that asset these viral proteins in different 
tissues.  
RNA-binding proteins (RBPs) and miRNAs (micro-RNAs) have been widely recognized in 
regulating the post-transcriptional gene regulatory network in humans [24-26]. Dysregulated RBPs 
and miRNAs have been shown to contribute significantly to altered regulatory network in a 
plethora of diseases such as cancer, genetic diseases and viral infections [27-33]. Till date, the 
potential RBPs and miRNAs that either interact directly with the virus or cross talk with each other 
to facilitate SARS-CoV-2 infection has not been investigated and hence require a systematic 
investigation of their role in SARS-SoV-2 infection.  
Currently, there are no proven vaccines or anti-viral therapies that are effective against the novel 
coronavirus. Although, analysis of therapeutic targets for SARS-CoV-2 has been conducted to 
identify potential drugs by computational methods [34], the targets have not clinically approved 
for vaccine development. Alternative therapeutics like angiotensin receptor blockers have been 
identified as tentative vaccine candidates but have shown concerns associated with disrupted 
angiotensin functions crucial for cell [35]. Therefore, to devise effective therapeutics, there is a 
need to determine the cellular targets in humans that interact with the virus and result in altered 
functional outcomes. In this study, we uncovered that several human RBPs and miRNAs harbor 
abundant binding sites across the SARS-CoV-2 genome, illustrating the titration of post-
transcriptional regulators. Interestingly, we show that most of these regulators were predominantly 
expressed in gonadal tissues, adrenal, pancreas, and blood cells. Overall, this study will bridge the 
gap in our understanding of the impact of SARS-CoV-2 infection on post-transcriptional 
regulatory networks.  
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RESULT AND DISCUSSION 
Protein-protein interaction network analysis suggest an immediate interaction of 
functionally important human RBPs with SARS-CoV-2 viral proteins 
We obtained the affinity purification-mass spectrometry (AP-MS) based SARS-CoV-2 and human 
proteins interaction network established in HEK293 cells [23]  and investigated the human RBPs 
that directly interact with viral proteins. Our analysis revealed that SARS-CoV-2 encoded proteins 
interact directly with 51 human RBPs (Fig.1A). We observed that these primary interacting RBPs 
were proven to serve several vital functions in the cells including RNA processing enzymes such 
as polyadenylate binding protein 4 (PABP4) and Dead-box helicases (DDX21 and DDX10), 
enzymes involved in translation machinery such as  eukaryotic translation initiation factor 4H 
(EIF4H) and ribosomal protein L36 (RPL36) (Fig. 1A). Among these immediate interactions, we 
also found human RBPs such as signal recognition particle 19 (SRP19 and SRP54) and Golgin 
subfamily B member 1 (GOLGB1) that have been well recognized for co-translational protein 
targeting to membrane and ER to Golgi vesicle-mediated transport [36, 37] (Fig. 1A). These results 
suggest that several human RBPs that come in direct contact with SARS-CoV-2 proteins could 
contribute to virus assembly and export. However, such findings require in-depth experimental 
validation to support the functional involvement of the identified RBPs in response to SARS-CoV-
2 infection.  
Further, we observed that among the SARS-CoV-2 encoded proteins, majority of direct 
interactions occurred with a range of non-structural proteins (nsp 2,5,8,9,11,13) that contribute to 
viral replication and transcription along with structural proteins (E,N and M) (Fig. 1A). It is likely 
that these identified RBPs assist in the viral transcription in the host cell. Furthermore, we also 
observed ~65% of annotated human RBPs [38] were in immediate neighborhood (obtained from 
BioGRID, shown at the center in Fig. 1A) of virus-protein interacting RBPs  and could indirectly 
regulate the SARS-CoV-2 proteins, representing a comprehensive network of human RBPs and 
SARS-CoV-2 proteins likely to rewire the post-transcriptional gene regulatory mechanisms in 
human cells.  
Next, we examined the abundance of SARS-CoV-2 interacting RBPs across human tissues using 
the protein expression data from human proteome map[39]. Our results suggest that majority of 
the human RBPs that have direct interaction with SARS-CoV-2 proteins were predominantly 
expressed in gonadal tissues (testis and ovary) (Fig. 1B). These findings agreed with a recent study 
showing that male reproductive systems are vulnerable to SARS-CoV-2 infection, that was evident 
by dramatic changes in sex hormones of the infected patients suggesting gonadal function 
impairment [40, 41]. Additionally, we also found that, these SARS-CoV-2 interacting human 
RBPs were showing relatively higher expression in immune cell types such as T cells (CD4+ and 
CD8+) and NK cells that are a part of innate anti-viral immune response (Fig. 1B). Our 
observations are supported by recently published studies suggesting that T cells, CD4+ T cells, 
and CD8+ T cells play a significant antiviral role during SARS-CoV-2 infection [20, 42-45]. 
Overall, the results from this analysis provide a systematic dissection of potential RBPs in humans 
interacting with SARS-CoV-2 proteins across tissues.  
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SARS-CoV-2 infected lung epithelial cells reveal the enrichment of several immunological 
and metabolic pathways.  
Due to rapidly evolving nature of SARS-CoV-2, the transcriptomic alterations contributed by the 
virus in humans remains unclear. To gain insight into the effect of SARS-CoV-2 infection on host 
gene expression, we obtained the raw RNA sequencing data in normal versus SARS-CoV-2 
infected human bronchial epithelial (NHBE) cells [46] deposited in Gene Expression Omnibus 
(GEO) [47]. We investigated the differentially expressed genes between the mock treated versus 
SARS-CoV-2 infected cells and assessed the functional pathways associated with these genes 
(Fig. 2A, Fig. S1). Functional analysis of differentially expressed genes (at 5% fdr) using ClueGo 
[48] revealed an enrichment for immune response, cytokine mediated signaling, inflammatory 
response and metabolism associated genes (Fig. 2A, Table S1). 
 
We observed a significant enrichment for the IL-17 pathway associated genes during SARS-CoV-
2 infection (Fig. 2A). Our observation of overrepresented IL-17 pathway was in accordance with 
recent studies that show overactivation of IL-17 producing Th17 cells during severe immune 
injury in SARS-CoV-2 patients [49-51]. In addition to this, a recent review has summarized that 
targeting IL-17 is immunologically plausible as a therapeutic strategy to prevent acute respiratory 
distress syndrome (ARDS) during SARS-CoV-2 infection, based on previous evidence that mice 
lacking functional IL-17 receptor (Il17ra−/−) signaling were shown to be more susceptible than 
wild-type mice to secondary pneumonia following infection with influenza A [52, 53]. Thus, our 
analysis shows several enriched pathways including IL-17 cytokine response in SARS-CoV-2 
infected cells.  
 
We also provide parallel support for the dysregulation of multiple RNA binding proteins (FLNB, 
HDGF, ASS1, ZC3H12A, HK2, BST2, PPARGC1A) involved in immune response, cytokine 
mediated signaling, and metabolism by employing mock treated versus SARS-CoV2 infected 
lung cells (Fig. 2B). We also observed that six of these differentially expressed genes that encode 
for RBPs were involved in at least 30% of the overrepresented pathways. Overall, our results 
imply that differentially expressed genes in SARS-CoV-2 infected cells may contribute to 
alterations in the post-transcriptional regulatory networks governed by the RBPs encoded by 
them.  
 
Alternative splicing analysis revealed the abundance of skipped and mutually exclusive 
exons during SARS-CoV-2 infection in lung epithelial cells. 
Alternative splicing is a principal mechanism that contributes to protein diversity in eukaryotes, 
while regulating physiologically important immune responses during bacterial and viral infections 
[54]. Viral infections have been shown to cause global changes in the alternative splicing 
signatures in the infected cells that may arise due to intrinsic factors like polymorphism at the 
splice sites or due to direct intervention by virulence factors [55-57]. A previous study on virus-
host interactions has demonstrated that human coronavirus targets various signaling pathways of 
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ER stress resulting in differential splicing outcomes [58]. Another study has shown that deletion 
of E protein in recombinant SARS-CoV resulted in significant XBP1 gene splicing and higher rate 
of apoptosis, suggesting that coronavirus infected cells are susceptible to differential splicing 
events [59]. Therefore, we next investigated the alternative splicing events in mock vs SARS-CoV-
2 treated NHBE cells  using rMATS (replicate Multivariate Analysis of Transcript Splicing) [60].  
Our analysis revealed an abundance for skipped and mutually exclusive exonic events in the genes 
exhibiting alternative splicing events during SARS-CoV-2 infection at 5% fdr (Fig. 3A). We also 
observed that 81 of the alternatively spliced genes encoded for RBPs (indicated in blue, Fig. 3A)  
and hence could result in altering the downstream post-transcriptional regulatory networks in 
SARS-CoV-2 infected cells (Fig. 3A). These findings enhance our mechanistic understanding of 
the SARS-CoV-2 induced alternative splicing dyregulation in human cells and could be critical 
for developing novel therapeutic strategies. Next, we identified the functional annotation of the 
enriched GO-terms related to the genes exhibiting alternative splicing using ClueGO [48]. Our 
data revealed that majority of these genes were enriched for vital biological processes including 
cellular protein localization, protein metabolism, organelle organization, cellular biosynthetic 
process, cellular component assembly and cytochrome c-mediated apoptotic response (Fig. 3B). 
These findings suggest that SARS-CoV-2 infection could dysregulate the functionally important 
biological catalogue via alternatively spliced genes predominantly through skipped exons and 
mutually exclusive exons. In summary, this analysis provides a clustered network of enriched 
biological functions that could be significantly dysregulated in SARS-CoV-2 infected cells.  
Motif enrichment analysis reveals potential human RBPs titrated by SARS-CoV-2 viral 
genome.  
SARS-CoV-2 genome is the largest among the coronavirus family (~30kb) and has been attributed 
to enhanced virus pathogenicity in the newly evolved strains of COVID-19 pandemic [18, 61]. 
Among the host derived cellular factors, RBPs have been recognized as active participants in all 
steps of viral infection [29, 62, 63]. A recent review has shown linkage of 472 human proteins 
with viruses through unconventional RNA binding domains [63]. In the present research, we 
conducted a systematic and comprehensive bioinformatic study to investigate the RBPs that could 
potentially bind on RNA genome of SARS-CoV-2 by motif enrichment analysis of human RBPs 
using FIMO [64]. Motif analysis for RBPs with established position specific weight matrices 
(PWMs) revealed significant number of binding sites spread across the SARS-CoV-2 genome 
illustrating the possible titration of post-transcriptional regulators by viral genome (Fig. 4A, Fig. 
S2). Importantly, the binding pattern of the RBP motifs across the entire normalized length of the 
virus suggesting that, several of human RBPs could be titrated randomly across the viral genome 
(Fig. 4A). Our results showed an enrichment for RBPs such as SRSFs, PCBPs, ELAVs and 
HNRNPs being most likely to get sponged on the viral genome (Fig. 4B). Specifically, our 
observation of RBPs well known for their role in splicing such as SRSF7, HNRNPA1 and TRA2A 
was in accordance with a recently published study that predicted binding sites of these RBPs on 
SARS-CoV-2 RNA [65]. In summary, these findings suggest that SARS-CoV-2 could sponge 
human RBPs on its genome resulting in altered post-transcriptional gene regulatory network in the 
host cells. Targeting host proteins has been appreciated as an effective strategy to combat a wide 
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range of viral infections and therefore an understanding of the potential RBPs that are likely 
sponged on the viral genome is crucial to develop novel therapeutics [30]. 
SARS-CoV-2 genome titrates the abundance of functionally important miRs in human tissue  
Micro RNAs (miRs) are small non-coding RNA molecules that function as central regulators of 
post-transcriptional gene regulation. Human miRs have been associated with a variety  of 
pathophysiological pathways and demonstrate differential expression during viral infections [66, 
67]. Recently, a machine learning based study predicted that miRs could impact SARS-CoV-2 
infection through several mechanisms such as interfering with replication, translation and even 
modulating the host gene expression [68]. In this study, we used computational approach to 
investigate the potential binding sites of human miRs in SARS-CoV-2 genome using FIMO [64]. 
We identified 22 miRNAs that could potentially bind throughout the length of the SARS-CoV2 
viral genome (Fig.5A, Table S5). These results suggest that several important miRs are likely being 
titrated by SARS-CoV-2 genome that could result in dysregulation of post-transcriptional 
networks in the infected cells. 
Majority of the identified miRs were highly expressed in immune cells including CD8+T cells, 
CD4+T, NK cells, CD14 cells and mast cells, suggesting that these miRs might contribute to 
altered post-transcriptional regulation in specialized immune cells and could contribute to the 
progression of the viral infection and host immune response across other human tissues (Fig.5B). 
Our results also indicate that the high confident genes targeted by these sponged miRs were 
enriched for functional themes including ‘regulation of metabolic processes’, ‘post transcriptional 
gene regulation’ and ‘cell to cell communication’ suggestive of a large-scale dysregulation across 
tissues (Fig.5C). Overall, our results present a comprehensive analysis of the miRs being 
potentially titrated on the viral genome resulting in altered post-transcriptional gene regulation. 
These findings provide important clues that enhances our understanding of miR associated 
mechanism in viral pathogenesis.   
 
CONCLUSION 
Our analysis integrates a comprehensive interaction network to map the immediate interactions 
between SARS-CoV-2 genome and proteome with human post-transcriptional regulators such as 
RBPs and miRNAs along with their tissue specific expression and functional annotations. Given 
the importance of developing effective therapeutic strategies in the current pandemic, 
understanding the effect of SARS-CoV-2 infection on human transcriptional and post-
transcriptional regulatory networks is crucial for identifying effective drug targets. To delineate 
the impact of SARS-CoV-2 on host cells post-transcriptional gene regulatory network, we 
integrated the immediate interactions between SARS-CoV-2 encoded proteins with human RNA 
binding proteins. Our findings indicate 51 human RBPs interact directly with the viral structural 
and non-structural proteins, that in turn interact indirectly with ~65% other secondary neighbor 
RBPs. We show that the expression profiles of majority of the directly interacting RBPs were 
associated with gonadal tissues and immune cell types. Our study highlights that several of the 
differentially expressed genes in SARS-CoV-2 infected cells were enriched for biological 
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pathways such as immune response, cytokine mediated signaling, inflammatory response and 
metabolism associated genes that are indispensable for cell survival. Importantly, we found that 
among the differentially expressed genes, six genes encoded for RBPs implying a potential impact 
of SARS-CoV-2 infection on post-transcriptional regulation. Further, our analysis demonstrates 
the abundance of skipped exonic and mutually exclusive exonic events in the SARS-CoV-2 
infected cells, suggesting these alternative splicing events as a plausible cause for altered post-
transcriptional regulation in human cells. Using motif enrichment analysis, we show that two key 
post-transcriptional regulators, RBPs and miRs are likely to be titrated by SARS-CoV-2 genome 
that could result in dysregulated transcriptional regulation in the infected cells. Currently, there are 
no anti-viral therapies or vaccines available for COVID-19. Therefore, our analyses provide a 
roadmap to enhance our understanding of the interactions of SARS-CoV-2 with key pos-
transcriptional regulators in the human genome.  
 
MATERIALS AND METHODS 
Dissection of SARS-CoV-2 proteins interacting with human RBPs 
We obtained the high confidence mass spectrometry based SARS-CoV-2 viral protein to human 
protein interaction network established by Gordan et al, 2020 [23] in HEK293 cells. We dissected 
the human RBPs directly interacting with viral proteins and integrated with 1st neighbor interacting 
RBPs (obtained from BioGRID). We also extracted the protein abundance of these SARS-CoV2 
interacting RBPs across human tissues from Human Proteome Map [39]. The abundance of these 
proteins were hierarchically clustered and row normalized and represented as heatmap generated 
from Morpheus (https://software.broadinstitute.org/morpheus/).  
Differential expression analysis of mock treated versus SARS-CoV-2 infected primary 
human lung epithelial cells.  
We downloaded the raw RNA sequencing data deposited in Gene Expression Omnibus (GEO)[47]. 
Specifically, we downloaded the paired end raw sequencing (FASTQ) files of mock treated and 
SARS-CoV-2 (USA-WA1/2020) infected primary human lung epithelial cells (in biological 
triplicates) using the Sequence Read Archive (SRA) Toolkit (fastq-dump command), from the 
GEO cohort GSE147507 [46]. The quality of the sequence reads were ensured using FASTX-
Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) with a minimum of Phred quality score 20 for 
each sample. We processed the raw sequencing reads using the in-house NGS data processing 
pipeline as described previously[69, 70]. Briefly, we used Hierarchical Indexing for Spliced 
Alignment of Transcripts (HISAT) [71] for aligning the short reads from RNA-seq experiments 
onto human reference genome (hg38). SAM (Sequence Alignment/Map) files obtained from 
HISAT were post-processed using SAMtools (version 0.1.19) [72, 73] for converting SAM to 
BAM (Binary Alignment/Map) followed by sorting and indexing the output BAMs. The sorted 
BAM files were parsed using the python script provided by StringTie (version 1.2.1) [74] to obtain 
the count matrix of for gene levels across the samples. This count matrix was used to perform 
differential expression analysis between mock vs SARS-CoV-2 infected NHBE cells using DE-
seq2 [75]. Statistically significant (at 5% fdr) differentially expressed genes were collected for 
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downstream data analysis. Functional enrichment analysis of these genes waere performed with p-
value threshold < 10-10 using ClueGO [48] (a Cytoscape [76] plugin) and  were represented as bar-
plot illustrating the significant pathways obtained from GO-term based functional grouping of 
differentially expressed genes. 
Identification of alternative splicing events during SARS-CoV2 infection.  
We used rMATS (replicate Multivariate Analysis of Transcript Splicing) [60] to identify 
differential alternative splicing (AS) events between the mock vs SARS-CoV-2 treated NHBE 
cells. rMATS used sorted BAM (Binary Alignment/Map) files, obtained from aligning the fastq 
files against hg38 reference genome using HISAT (as discussed above). It also uses a GTF file 
(gene transfer file format), downloaded from Ensembl (version 97) [77] for existing annotation of 
exons. Briefly, rMATS enabled the analysis of  the inclusion/exclusion of target exons/introns 
contributing to different types of alternative splicing events, namely skipped exon (SE), alternative 
5’ splice site (A5SS), alternative 3’ splice site (A3SS), mutually exclusive exons (MXE) and 
retained intron (RI), between pair of conditions and provides the difference in level of inclusion of 
an exon denoted by Percentage Splicing Index (𝜓𝜓 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠) (as described previously [69]). Genes 
exhibiting alternatively spliced events detected below 5% FDR threshold were documented in 
Table S3. Functional enrichment analysis of these genes was performed using ClueGO [48]. 
 
Identification of potential binding blocks of RBPs in SARS-CoV-2 viral genome using motif 
enrichment analysis.  
We obtained the RBP-motifs from Attract[78] and scanned across the SARS-CoV-2 viral genome 
using FIMO[64, 79] with default parameters. Resulting genomic locations for each RBP motif 
were documented in Table S4. For each binding motif, the scanned genomic location was 
normalized by considering the mid-point of genomic coordinate divided with the SARS-CoV-2 
genome length. Also, the occurrence of each RBP motif binding across the viral genome was 
computed. Statistically significant (p-value < e-05) preferential binding profile of RBP motifs 
(sorted by frequency of binding and greater than 10 sites) across the SARS-CoV-2 viral genome 
(length normalized) identified using FIMO was visualized in violin plot. Also, the protein 
abundance of corresponding RBPs were extracted from human proteome map[39] and represented 
as hierarchically clustered heatmap across the tissues. 
Identification of potential binding blocks of microRNAs in SARS-CoV-2 viral genome using 
motif enrichment analysis.  
We obtained the miR-motifs from MEME[79] and scanned across the SARS-CoV-2 viral genome 
using FIMO[64, 79] with default parameters. Resulting genomic locations for each miR-motif 
were documented in Table S6. For each miR motif, the scanned genomic location was normalized 
by considering the mid-point of genomic coordinate divided with the SARS-CoV-2 genome 
length. Also, the occurrence of each miR-motif binding across the viral genome was computed. 
Statistically significant (p-value < e-05) preferential binding profile of miR-motifs (sorted by 
frequency of binding and greater than 15 sites) across the SARS-CoV-2 viral genome (length 
normalized) identified using FIMO was visualized in violin plot. Also, the expression profile of 
corresponding miRs were extracted from FANTOM5 project[80] and represented as hierarchically 
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clustered heatmap across the tissues. To understand the generic biological function of these miRs, 
that could be altered by being titrated by SARS-CoV-2 genome in host cells, we downloaded the 
high confidence miR target genes (obtained from miRNet [81, 82]) and  performed function 
annotation analysis. Resulting significant biological processes, obtained from gene ontology 
enrichment based functional grouping of these miR target genes were illustrated in barplot. 
Significant clustering (adj. p < 1e-10) of genes enriched in GO-biological processes were 
generated by ClueGO [48] analysis (a cytoscape [76] plugin). 
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Figure Legends: 
Figure 1. Protein-protein interaction network analysis suggest an immediate interaction of 
human RBPs with SARS-CoV2 viral proteins (A) An integrated SARS-CoV-2 – human RBP 
interaction network. We obtained the MS-based SARS-CoV-2 viral protein to human protein 
interaction network established in HEK293 cells and integrated with 1st neighbor interacting RBPs 
(obtained from BioGRID). (B) Protein abundance of SARS-CoV2 interacting RBPs across human 
tissues. Expression data were obtained from human protein map and row normalized. SARS-CoV-
2 proteins were color coded and highlighted in the network.  
Figure 2. Differential expression analysis of mock treated versus SARS-CoV-2 infected 
primary human lung epithelial cells. (A) Bar-plot illustrating the significant pathways obtained 
from GO-term based functional grouping of differentially expressed genes (at 5% fdr) using 
ClueGO analysis (Cytoscape plugin) (B) Row normalized expression profile of differentially 
expressed RBPs. 
Figure 3. Alternative splicing events during SARS-CoV2 infection. (A) Bar plot showing the 
genes (RBP encoding genes in blue) exhibiting alternative splicing during SARS-CoV-2 infection 
in primary human lung epithelial cells (at 5% fdr). (B) Clustered GO-term network obtained from 
function annotation analysis and grouping of the GO-term for the genes exhibiting alternative 
splicing using ClueGo (cytoscape plugin). Significant clustering (adj. p < 1e-05) of functional 
groups were color coded by functional annotation of the enriched GO-biological processes, with 
size of the nodes indicating the level of significant association of genes per GO-term, were shown. 
Figure 4. Motif enrichment analysis reveals potential human RBPs titrated by SARS-CoV-2 
viral genome. (A) Violin plot shows the statistically significant (p-value < e-05) preferential 
binding profile of RBP motifs (sorted by frequency of binding and greater than 10 sites) across the 
SARS-CoV-2 viral genome (length normalized) identified using FIMO. (B) Hierarchically 
clustered heatmap showing the protein abundance (row normalized) of RBPs across tissues. 
Figure 5. SARS-CoV-2 genome titrates the abundance of functionally important miRs in 
human tissue (A) Violin plot shows the statistically significant (p-value < e-05) preferential 
binding profile of miR- motifs (sorted by frequency of binding >15 sites) across the SARS-CoV-
2 viral genome (length normalized) identified using FIMO. (B) Hierarchically clustered heatmap 
showing the log10 expression (CPM, row normalized) of miRs across tissues. (C) Bar-plot 
illustrating the significant biological processes, obtained from gene ontology enrichment based 
functional grouping of miR target genes (obtained from miRNet). Significant clustering (adj. 
p < 1e-10) of genes enriched in GO-biological processes generated by ClueGO analysis (cytoscape 
plugin). 
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Figure 2. Differential expression analysis of mock treated versus SARS-CoV-2 infected 
primary human lung epithelial cells. (A) Bar-plot illustrating the significant pathways 
obtained from GO-term based functional grouping of differentially expressed genes (at 5% 
fdr) using ClueGO analysis (Cytoscape plugin) (B) Row normalized expression profile of 
differentially expressed RBPs. 
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Figure 3. Alternative splicing events during SARS-CoV2 infection. (A) Bar plot showing the 
genes (RBP encoding genes in blue) exhibiting alternative splicing during SARS-CoV-2 
infection in primary human lung epithelial cells (at 5% fdr). (B) Clustered GO-term network 
obtained from function annotation analysis and grouping of the GO-term for the genes exhibiting 
alternative splicing using ClueGo (cytoscape plugin). Significant clustering (adj. p < 1e-05) of 
functional groups were color coded by functional annotation of the enriched GO-biological 
processes, with size of the nodes indicating the level of significant association of genes per GO-
term, were shown.
.CC-BY-ND 4.0 International licensewas not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprint (whichthis version posted July 6, 2020. . https://doi.org/10.1101/2020.07.06.190348doi: bioRxiv preprint 
Figure 4. Motif enrichment analysis reveals potential human RBPs titrated by SARS-CoV-2 viral 
genome. (A) Violin plot shows the statistically significant (p-value < e-05) preferential binding 
profile of RBP motifs (sorted by frequency of binding and greater than 10 sites) across the SARS-
CoV-2 viral genome (length normalized) identified using FIMO. (B) Hierarchically clustered 
heatmap showing the protein abundance (row normalized) of RBPs across tissues. 
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Figure 5. SARS-CoV-2 genome titrates the abundance of functionally important miRs in human tissue 
(A) Violin plot shows the statistically significant (p-value < e-05) preferential binding profile of miR- 
motifs (sorted by frequency of binding >15 sites) across the SARS-CoV-2 viral genome (length 
normalized) identified using FIMO. (B) Hierarchically clustered heatmap showing the log10 
expression (CPM, row normalized) of miRs across tissues. (C) Bar-plot illustrating the significant 
biological processes, obtained from gene ontology enrichment based functional grouping of miR target 
genes (obtained from miRNet). Significant clustering (adj. p < 1e-10) of genes enriched in GO-
biological processes generated by ClueGO analysis (Cytoscape plugin). 
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Figure S1. Protein-protein interaction network of differentially expressed genes in mock treated 
versus SARS-CoV-2 infected primary human lung epithelium (NHBE cells) where node size and 
color show the absolute and relative log2 fold changes, respectively. 
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Supplementary Table Legends: 
Table S1. Significant biological pathways obtained from functional annotation analysis of 
differentially expressed genes (at 5% fdr)  in mock treated versus SARS-CoV-2 infected 
primary human lung epithelium (NHBE cells) using ClueGO (a cytoscape plugin). 
Table S2. Identification of alternative splicing events using rMATS (replicate 
Multivariate Analysis of Transcript Splicing) in mock treated versus SARS-CoV-2 infected 
primary human lung epithelium (NHBE cells). 
Table S2. Significant biological pathways obtained from functional annotation analysis of 
alternatively spliced genes (at 5% fdr) in mock treated versus SARS-CoV-2 infected 
primary human lung epithelium (NHBE cells) using ClueGO (a cytoscape plugin). 
Table S4. Preferential binding location of RBP motifs identified by FIMO across the SARS-CoV2 
viral genome. 
Table S5. Preferential binding location of miR-motifs identified by FIMO across the SARS-CoV2 
viral genome. 
Table S6. Significant biological pathways obtained from functional annotation analysis of 
mir-targeted genes (from mirNet) using ClueGO (a cytoscape plugin). 
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